Following on from his time in BioInnovate, Fergal and his teammate, Alison Liddy, created a company, Capri Medical, focusing primarily on developing an implantable medical device for chronic peripheral nerve pain. The company leveraged seed funding from the Enterprise Ireland Commercialisation Fund to recently complete its first preclinical trial with strong results. Fergal and Alison’s ambition is to seek Series A investment to further prove the technology in first-in-man trials and bring it commercially to market in the coming years.